| DAA183 |
protein phosphatase 2 (formerly 2A), regulatory subunit A, alpha isoform |
PPP2R1A |
6.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA184 |
protein phosphatase 5, catalytic subunit |
PPP5C |
7.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA397 |
protein tyrosine phosphatase, non-receptor type 3 |
PTPN3 |
4.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
| DAA190 |
protein tyrosine phosphatase, receptor type, E |
PTPRE |
39.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA360 |
protein tyrosine phosphatase, receptor type, J |
PTPRJ |
11.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA369 |
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae) |
PRPF8 |
2.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA2416 |
pyridoxal (pyridoxine, vitamin B6) kinase increases with age |
PDXK |
17.2% Increase DNA Methylation |
dermis |
Human |
|
| DAA464 |
pyruvate dehydrogenase complex, component X |
PDHX |
4.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
| DAA516 |
pyruvate dehydrogenase (lipoamide) alpha 1 |
PDHA1 |
3.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
| DAA395 |
pyruvate dehydrogenase (lipoamide) beta |
PDHB |
4.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
| DAA192 |
quaking homolog, KH domain RNA binding (mouse) |
QKI |
8.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA512 |
RAB10, member RAS oncogene family |
RAB10 |
2.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA428 |
RAB11A, member RAS oncogene family |
RAB11A |
3.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA193 |
RAB2A, member RAS oncogene family |
RAB2A |
11.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA194 |
RAB3A, member RAS oncogene family |
RAB3A |
11.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA203 |
radixin |
RDX |
13.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA422 |
Ral GTPase activating protein, alpha subunit 1 (catalytic) |
RALGAPA1 |
3.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA2429 |
RANBP2-like and GRIP domain containing 5 isoform 2 decreases with age |
RGPD5 |
20.4% Decrease DNA Methylation |
dermis |
Human |
|
| DAA2077 |
RAN, member RAS oncogene family decreases with age |
RAN |
40.1% Decrease Gene Expression Level |
ovary |
Human |
|
| DAA197 |
RAP2A, member of RAS oncogene family |
RAP2A |
28.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA200 |
Ras association (RalGDS/AF-6) domain family member 2 |
RASSF2 |
18.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA199 |
Ras protein-specific guanine nucleotide-releasing factor 1 |
RASGRF1 |
22.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA278 |
Ras-related GTP binding D |
RRAGD |
14.0% Decrease Gene Expression Level |
kidney |
Human |
|
| DAA196 |
receptor (G protein-coupled) activity modifying protein 1 |
RAMP1 |
16.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA206 |
regucalcin (senescence marker protein-30) |
RGN |
15.0% Increase Gene Expression Level |
brain |
Human |
|